| Spectrum of disease associated with partial lipodystrophy: lessons from a trial cohort N Ajluni, R Meral, AH Neidert, GF Brady, E Buras, B McKenna, F DiPaola, ... Clinical endocrinology 86 (5), 698-707, 2017 | 81 | 2017 |
| The SRG rat, a Sprague-Dawley Rag2/Il2rg double-knockout validated for human tumor oncology studies FK Noto, J Sangodkar, BT Adedeji, S Moody, CB McClain, M Tong, ... PloS one 15 (10), e0240169, 2020 | 17 | 2020 |
| Metreleptin therapy for nonalcoholic steatohepatitis: Open-label therapy interventions in two different clinical settings B Akinci, A Subauste, N Ajluni, NH Esfandiari, R Meral, AH Neidert, ... Med 2 (7), 814-835. e6, 2021 | 13 | 2021 |
| Potential association of LMNA-associated generalized lipodystrophy with juvenile dermatomyositis M Sahinoz, S Khairi, A Cuttitta, GF Brady, A Rupani, R Meral, MK Tayeh, ... Clinical diabetes and endocrinology 4 (1), 1-6, 2018 | 9 | 2018 |
| Lead findings from Pterocarpus santalinus with hepatoprotective potentials through in silico methods BK Manjunatha, R Amit, P Priyadarshini, K Paul Int J Pharma Sci and Res 7, 265-70, 2010 | 9 | 2010 |
| Alloimperatorin from Aegle Marmelos- A promising lead molecule for hepatoprotection – in vivo and in silico approach AR B.K.Manjunatha International Journal of Current Research 3 (12), 005-010, 2011 | 2 | 2011 |
| SCREENING OF NOVEL INHIBITOR FOR HER2 INDUCED BREAST CANCER-AN INSILICO APPROACH AR Rupani, B Bhattacharjee International Journal of Pharmaceutical Sciences and Research 2 (1), 153, 2011 | 2 | 2011 |
| VISTA promotes the metabolism and differentiation of myeloid-derived suppressor cells by STAT3 and polyamine-dependent mechanisms K Zhang, A Zakeri, T Alban, J Dong, HM Ta, AH Zalavadia, A Branicky, ... Cell reports 43 (1), 2024 | 1 | 2024 |
| Topological heterogeneity of genomic and immunologic effects from combination immunotherapy treatment in the neoadjuvant setting for renal cell carcinoma (RCC). T Alban, S Singh, PG Pavicic, PA Rayman, PP Bangalore, A Rupani, ... Journal of Clinical Oncology 42 (4_suppl), 454-454, 2024 | | 2024 |
| Phase II Clinical Trial of Pembrolizumab and Chemotherapy Reveals Distinct Transcriptomic Profiles by Radiologic Response in Metastatic Triple-Negative Breast Cancer AD Wilkerson, PB Parthasarathy, N Stabellini, C Mitchell, PG Pavicic Jr, ... Clinical Cancer Research 30 (1), 82-93, 2024 | | 2024 |
| Immunotherapy with IL12 and PD1/CTLA4 inhibition is effective in advanced ovarian cancer and associates with reversal of myeloid cell-induced immunosuppression PG Pavicic Jr, PA Rayman, S Swaidani, A Rupani, V Makarov, ... OncoImmunology 12 (1), 2198185, 2023 | | 2023 |
| 935 VISTA regulates the differentiation of myeloid-derived suppressor cells by STAT3-dependent modulation of arginase-1 and iNOS expression and mitochondrial function K Zhang, A Zakeri, T Alban, J Dong, H Ta, A Zalavadia, A Branicky, ... Journal for ImmunoTherapy of Cancer 11 (Suppl 1), 2023 | | 2023 |
| Mapping of anti-inflammatory phytochemicals on cancer drug target network using Systems Biology approach PP Amit Rupani, BiplabhBhattacharjee International Journal of Current Research 33 (2), 001-005, 2011 | | 2011 |
| Comparative analysis of Plant and Animal Fungal Pathogens to identify Putative Drug Targets- A Subtractive Genomics Approach TT Asheesh Shanker, Ruchi Jain, Amit Rupani, Anushree Mukerji International Journal of Current Research 11, 123-128, 2010 | | 2010 |
| " Banasthali University, Rajasthan, India.“The Oxford College of Engineering, Bangalore, India. A Shanker, R Jain, AR Rupani, A Mukerji, T Tiwari | | |
